FdaApplication

NDA 220711

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBEONE MEDICINES USA INC
application_typeNDA
approval_date2026-05-13

Products (4)

ProductActive ingredientStrengthDosage form
BEQALZISONROTOCLAX20MGTABLET;ORAL
BEQALZISONROTOCLAX80MGTABLET;ORAL
BEQALZISONROTOCLAX5MGTABLET;ORAL
BEQALZISONROTOCLAX1MGTABLET;ORAL

4 products